Drug Shortage Report for MAGNESIUM SULFATE INJECTION, USP
Report ID | 136534 |
Drug Identification Number | 02139499 |
Brand name | MAGNESIUM SULFATE INJECTION |
Common or Proper name | Magnesium Sulfate Injection 500 mg/mL PBP Vial 50 mL |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | MAGNESIUM SULFATE |
Strength(s) | 500MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 50 mL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-04-01 |
Estimated end date | Unknown |
Actual end date | 2022-12-15 |
Shortage status | Resolved |
Updated date | 2022-12-15 |
Company comments | On 100% allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v17 | 2021-07-29 | English | Compare |
v16 | 2021-07-29 | French | Compare |
v15 | 2021-07-29 | English | Compare |
v14 | 2021-07-29 | English | Compare |
v13 | 2021-07-29 | French | Compare |
v12 | 2021-07-29 | English | Compare |
v11 | 2021-04-23 | French | Compare |
v10 | 2021-04-23 | English | Compare |
v9 | 2021-04-05 | French | Compare |
v8 | 2021-04-05 | English | Compare |
v7 | 2021-04-05 | French | Compare |
v6 | 2021-04-05 | English | Compare |
v5 | 2021-04-05 | French | Compare |
v4 | 2021-04-05 | English | Compare |
v3 | 2021-04-02 | English | Compare |
v2 | 2021-03-29 | French | Compare |
v1 | 2021-03-29 | English | Compare |